Literature DB >> 1982458

Somatostatin acts through G-proteins on dopaminergic adenylate cyclase in the caudate-putamen of the rat.

A Moser1, H Cramer.   

Abstract

Somatostatin was incubated in an adenylate cyclase assay of a particulate fraction of caudate-putamen tissue of the rat in order to examine the effect of the peptide on D-1 receptor coupled adenylate cyclase in vitro. Somatostatin was able to enhance cyclic AMP formation in the presence of guanylylimidodiphosphate and guanosine-triphosphate. In contrast to this, somatostatin inhibited both dopamine and forskolin-stimulated cyclic AMP accumulation. Pertussis toxin and cholera toxin also depressed forskolin-induced stimulation. Somatostatin was found to antagonize these inhibitory effects of pertussis toxin and cholera toxin. The results suggest that somatostatin acts through a stimulatory as well as an inhibitory guanine nucleotide regulatory protein subtype to affect dopaminergic adenylate cyclase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982458     DOI: 10.1007/bf01101708

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

Review 1.  Adenylate cyclase assay.

Authors:  Y Salomon
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

2.  Assay of proteins in the presence of interfering materials.

Authors:  A Bensadoun; D Weinstein
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

3.  Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations.

Authors:  R Markstein; K A Stöckli; J C Reubi
Journal:  Neurosci Lett       Date:  1989-09-25       Impact factor: 3.046

4.  Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover.

Authors:  J A Garcia-Sevilla; T Magnusson; A Carlsson
Journal:  Brain Res       Date:  1978-10-20       Impact factor: 3.252

5.  'Barrel rotation' induced by somatostatin in the non-lesioned rat.

Authors:  M L Cohn; M Cohn
Journal:  Brain Res       Date:  1975-10-10       Impact factor: 3.252

6.  The structure of adenylate cyclase systems.

Authors:  M Rodbell; P M Lad; T B Nielsen; D M Cooper; W Schlegel; M S Preston; C Londos; E S Kempner
Journal:  Adv Cyclic Nucleotide Res       Date:  1981

7.  Transient and steady state kinetics of the interaction of guanyl nucleotides with the adenylyl cyclase system from rat liver plasma membranes. Interpretation in terms of a simple two-state model.

Authors:  L Birnbaumer; T L Swartz; J Abramowitz; P W Mintz; R Iyengar
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

8.  Occurrence of a hormone-sensitive inhibitory coupling component of the adenylate cyclase in S49 lymphoma cyc- variants.

Authors:  K H Jakobs; G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation.

Authors:  A Moser; C Reavill; A Liebetrau; P Jenner; C D Marsden; H Cramer
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

10.  Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the rat.

Authors:  A Moser; C Reavill; P Jenner; C D Marsden; H Cramer
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

View more
  1 in total

1.  Neurotransmitter-mediated inhibition of post-mortem human brain adenylyl cyclase.

Authors:  A Garlind; C J Fowler; I Alafuzoff; B Winblad; R F Cowburn
Journal:  J Neural Transm Gen Sect       Date:  1992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.